Blog

Pashtoon Kasi: Circulating tumor DNA as an evolving tool in solid organ transplantation

Photo from Pashtoon Kasi/LinkedIn

Nov 23, 2024, 10:39

Pashtoon Kasi: Circulating tumor DNA as an evolving tool in solid organ transplantation

Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared on LinkedIn:

“As International Society of Liquid Biopsy kicks off tomorrow, see our chapter on circulating tumor DNA (ctDNA) as an evolving tool in solid organ transplantation.

Multiple caveats/challenges.
Remember the transplanted organ is also shedding DNA.”

Chapter 14 – Circulating tumor DNA (ctDNA) as a new and evolving tool in solid organ transplantation

Author: Pashtoon Murtaza Kasi

Pashtoon Kasi

More posts featuring Pashtoon Kasi.

Dr. Pashtoon Kasi is the Medical Director of GI Medical Oncology at City of Hope, Orange County. Previously, Dr. Kasi served as an Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Iowa, following positions as an Assistant Professor of Medicine and Oncology at both the University of Iowa and Mayo Clinic.

He also served as the Director of Colon Cancer Research and Director of Precision Medicine Research for Liquid Biopsies at Weill Cornell Medicine.His research primarily focuses on “liquid biopsies,” particularly circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs).

Dr. Kasi is also recognized as an author and editor of several significant books, including “Research: What, Why, and How: A Treatise from Researchers to Researchers” and “Impact of Circulating Tumor DNA (ctDNA) in Patients with Gastrointestinal Malignancies.” His scholarly contributions extend to over 100 publications in esteemed peer-reviewed journals. He also received the Yvonne Award 2024 by OncoDaily in the “challenging the status quo” category.